Viewing Study NCT06883695


Ignite Creation Date: 2025-12-24 @ 1:58 PM
Ignite Modification Date: 2026-04-02 @ 10:19 PM
Study NCT ID: NCT06883695
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-12
First Post: 2025-03-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ⅰ Clinical Trial to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of SHR-3045 in Healthy Subjects
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module